Neuroscientific Biopharmaceuticals Ltd (ASX: NSB) — Healthcare · Share Price, Chart & Market Data
About: NeuroScientific Biopharmaceuticals Limited engages in the research and development of biomedical products targeting neurodegenerative conditions. Its lead product is the EmtinB drug for the treatment of optic nerve diseases, such as glaucoma. The company also develops StemSmart platform technology to treat inflammatory immune disorders. NeuroScientific Biopharmaceuticals Limited was incorporated in 2002 and is based in Perth, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.12 (+4.35%)
NSBNeuroscientific Biopharmaceuticals Ltd
Loading watchlist status…
Trade NSB now
Neuroscientific Biopharmaceuticals Ltd share price
NSB price activity
Last Price
Change (24hr)
AUD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 8:54 am GMT+0
NSB price performance
4.348%
5D
46.341%
1M
20%
YTD
118.182%
1Y
NSB price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
ASX rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 8:54 am GMT+0
NSB details
NSB Market Signals